- Filed
- Apr 23, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.04B sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 1.05B sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 1.03B sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $2.23B |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $298M |
| Capex | Q1 2026 · Mar 31, 2026 | $141M |
| Capex | Q1 2026 · Mar 31, 2025 | $205M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.67B |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.68B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.7B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.73B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $3.37B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.73B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $12.96B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $10.14B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $9.61B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $9.98B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.44B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $12.65B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $13.07B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $8.44B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $10.47B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $24.38B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $26.04B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.45 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $0.44 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.45 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $0.44 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $288M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $229M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $823M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $703M |
| Net Income | Q1 2026 · Mar 31, 2026 | $469M |
| Net Income | Q1 2026 · Mar 31, 2025 | $460M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $503M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $451M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.83B |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $2.44B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $940M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $651M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.77B |
| Revenue | Q1 2026 · Mar 31, 2025 | $3.09B |